ParadigMS is dedicated to improving Multiple Sclerosis patient care by translating science into clinically relevant continuing medical education for neurologists and residents in Europe, the Middle East and North Africa.
Date: October 31, 2024
Venue: Al Qasr Ballroom, Jeddah Hilton, Jeddah, Saudi Arabia
Agenda: MS and Special Populations
| 18:30-19:00 | Registration and Welcome Coffee | ||
| 19:00-19:45 | Lectures Chairs: B. Yamout (AE) Co-Chair: M. Alkhawajah (SA) |
||
| 19:00-19:04 | Welcome and Introduction - B. Yamout (AE) and C. Oreja-Guevara (ES) | ||
| 19:04-19:16 | Epidemiology of MS in the Middle East | S. Bohlega (SA) | |
| 19:16-19:28 | Pregnancy and Multiple Sclerosis: Safety Aspects and Treatment Modalities | C. Oreja-Guevara (ES) | |
| 19:28-19:40 | Managing Multiple Sclerosis in Individuals Aged 55 and Above | P. Vermersch (FR) | |
| 19:40-19:45 | Live Q&A & Panel Discussion | All faculty, facilitated by M. Alkhawajah (SA) | |
UNFOLDING THE SUBJECT MATTER
Multiple Sclerosis (MS) in the Middle East is seeing an increasing prevalence, with regional differences influenced by genetic, environmental, and socioeconomic factors. Understanding these patterns helps inform tailored approaches to MS diagnosis and treatment in this unique population.
Multiple sclerosis (MS) primarily affects women of childbearing age, with symptoms that can influence the ability to conceive and impact family planning decisions. Prof. Oreja-Guevara will present an update on “Pregnancy and Multiple Sclerosis: Safety Aspects and Treatment Modalities", providing the latest insights on this critical topic.
Managing MS in individuals aged 55 and above presents unique challenges due to the complex interplay between aging, comorbidities, immunosenescence, and MS pathophysiology. Prof. Patrick Vermersch will deliver a comprehensive review of “Managing Multiple Sclerosis in Individuals Aged 55 and Above”, discussing current knowledge and best practices in this evolving field.
FACULTY
Prof. Bassem I. Yamout
Neurology Institute Director
Harley Street Medical Centre
Abu Dhabi, United Arab Emirates
Prof. Mona Alkhawajah
Consultant Neurologist & Assistant Professor
Neuroscience Center, King Faisal Specialist Hospital and Research Center, Al Faisal University
Riyadh, Saudi Arabia
Prof. Saeed Bohlega
Consultant Neurologist, Professor of Neurology
King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia
Prof. Patrick Vermersch
Vice President of Research in
the fields of Life and Health
Sciences
University of Lille
Lille, France
Prof. Celia Oreja-Guevara
Vice Chair of Neurology
University Hospital San Carlos
Madrid, Spain
WHAT ARE THE KEY TAKEAWAYS FROM THIS SYMPOSIUM?
By attending this symposium you will:
- Find out how MS prevalence is rising in the Middle East, driven by unique genetic, environmental, and socioeconomic factors, highlighting the need for region-specific approaches to care.
- Understand the impact of multiple sclerosis and the use of MS disease-modifying therapies (DMTs) on fertility, pre-pregnancy, pregnancy, and the postpartum period.
- Learn about the associated risks, the importance of conception timing, and the planning required for stopping and starting DMTs in the context of MS and pregnancy.
- Gain insights into the evolving landscape of MS in older adults.
- Explore the available evidence on the efficacy and safety of DMTs in older patients, including critical decisions relating to the initiation, de-escalation, and discontinuation of DMTs
- Discover non-pharmacologic approaches for treating and caring for older persons with MS (PwMS), including physical therapy, neuromodulation therapies, cognitive rehabilitation, and psychotherapy.
TARGET AUDIENCE
- Specialists
- Neurologists
- Practitioners
- Researchers in the field of MS
REGISTRATION
Registration is complimentary and can be arranged via the online registration module upon registering for the congress pass.
With thanks to our sponsor, who supports this Symposium without any involvement in the elaboration of the presentations.
Access the Merck knowledge forum at http://academe-ms.com/
For more information visit:
2024.menactrims.org